Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |